It is of significance to note here that a recent Interventional study aimed at blockade of the renin-angiotensin system (RAS) with ACE-inhibitors or ARBs, in patients with type 1 diabetes, did not slow nephropathy progression [19]. The gene discussed is ACE; the disease is type 1 diabetes mellitus.